US panel backs Gilead Sciences' hepatitis C drug Zee News Washington: US Food and Drug Administration advisers have unanimously voted in favor of a highly anticipated hepatitis C drug from Gilead Sciences that holds promise for millions infected with the liver-destroying virus. All 15 members of the FDA's ... |
